A Phase 3 Open Label, Randomized Study of BMS-986205 Combined With Nivolumab With or Without Chemotherapy Versus Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
A Phase 3 Open Label, Randomized Study of BMS-986205 Combined With Nivolumab With or Without Chemotherapy Versus Chemotherapy in Participants With Previously Untreated Stage IV or Recurrent Non-Small Cell Lung Cancer
This is a study of experimental medication BMS-986205 given with Nivolumab with or without chemotherapy compared to chemotherapy in participants with previously untreated stage IV or recurrent non-small cell lung cancer.
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com
Inclusion Criteria:
Exclusion Criteria:
Other protocol defined inclusion/exclusion criteria could apply
Jd. Petropolis-Londrina, Paraná 86015-520, Brazil
Centro-porto Alegre, Rio Grande do Sul 90050-170, Brazil
Osaka-sayama-shi, Osaka 5898511, Japan
Kitaadachi-gun, Saitama 362-0806, Japan
Majadahonda - Madrid, 28222, Spain
?stanbul, 34890, Turkey (Türkiye)